Drug Profile
Filgrastim biosimilar - Bionaturis
Alternative Names: BNT002 - BionaturisLatest Information Update: 12 Nov 2021
Price :
$50
*
At a glance
- Originator Bionaturis
- Class Chemoprotectants; Granulocyte colony-stimulating factors; Neuroprotectants; Recombinant proteins
- Mechanism of Action Granulocyte colony stimulating factor receptor agonists; Granulocyte colony-stimulating factor replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Lysosomal storage diseases; Neutropenia
Most Recent Events
- 19 Nov 2020 Adhoc task: MOA updated as per filgrastim thes term, removed G CSF stimulants, AN request sent
- 22 Aug 2016 Discontinued for Neutropenia in Spain (unspecified route)
- 01 Jan 2015 No development reported for Neutropenia in Spain (unspecified route)